BioDlink posts stable share base in July 2026; outstanding shares remain at 772.79 million

Bulletin Express08-05

BioDlink International Company Limited (BioDlink) filed its monthly return for the period ended 31 July 2026, confirming no movements in either issued or treasury shares. The number of ordinary shares in issue stayed at 772.79 million, with zero treasury shares on the balance sheet.

The company reconfirmed compliance with Hong Kong’s 25 percent minimum public-float requirement.

Under the Pre-IPO Share Option Scheme adopted on 20 February 2013, 0.02 million options were outstanding at month-end, unchanged from the previous month, and no options were granted, exercised, cancelled or lapsed. The options, if fully exercised, would expand the share base by only 0.00 percent.

No warrants, convertibles, or other share-issuance arrangements were outstanding, and no proceeds were raised during the month.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment